Artin Asadourian is a seasoned Biotech Executive with over 20 years of new product development and commercialization experience. During his career Artin has successfully held positions in R&D, Clinical Development, Global Strategic Marketing and New Product Commercialization at Amylin, Amgen, Wyeth, DuPont-Merck and Bayer Healthcare.

Soumitra Ghosh is a biotechnology industry executive with extensive experience in drug discovery and drug development. His expertise is in formulating R&D strategy, building and directing research programs, technology licensing, developing partnering collaborations, and in managing intellectual property portfolios.

David Maggs is a Pharmaceutical Executive who has expertise in the areas of drug discovery, clinical development and product commercialization.

His pharmaceutical industry experience includes leadership positions at Parke Davis, Pfizer, Amylin Pharmaceuticals and Bristol Myers Squibb.

David Litzinger has over 21 years of industry experience in drug discovery and development. He played key roles in the identification of several developable medicines and their advancement to market, including products that reached commercialization (Kineret®, Sensipar®, and Myalept™) as well as several compounds and formulations that have entered clinical stage evaluation.